Fortis Life Sciences Revenue and Competitors

Location

#9024

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Fortis Life Sciences's estimated annual revenue is currently $23.9M per year.(i)
  • Fortis Life Sciences's estimated revenue per employee is $155,000

Employee Data

  • Fortis Life Sciences has 154 Employees.(i)
  • Fortis Life Sciences grew their employee count by 7% last year.

Fortis Life Sciences's People

NameTitleEmail/Phone
1
COO, Co-founderReveal Email/Phone
2
VP, Corporate ControllerReveal Email/Phone
3
VP, Global Mergers & AcquisitionsReveal Email/Phone
4
VP SalesReveal Email/Phone
5
VP Global SalesReveal Email/Phone
6
SVP & Technical Development AbcoreReveal Email/Phone
7
SVP & Operations AbcoreReveal Email/Phone
8
VP FinanceReveal Email/Phone
9
Director Monoclonal Antibody DevelopmentReveal Email/Phone
10
Chief Commercial Officer (CCO)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Fortis Life Sciences?

keywords:N/A

N/A

Total Funding

154

Number of Employees

$23.9M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fortis Life Sciences News

2022-04-20 - Pricing pressures, high raw material costs could cast damper on Q4 pharma earnings

Nomura has a buy call on Torrent Pharma, Zydus Lifesciences, Lupin, Fortis and Apollo Hospitals, a neutral rating on Gland Pharma and a...

2022-03-22 - Fortis Life Sciences Partners With AccuGenomics to Expand ...

Fortis Life Sciences Partners With AccuGenomics to Expand Genomics Portfolio. March 29, 2022 08:00 AM Eastern Daylight Time. WALTHAM, Mass.--(BUSINESS...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$37.3M1546%N/A
#2
$22.9M15412%N/A
#3
$30.5M1548%N/A
#4
$300M15414%N/A
#5
$25.4M1548%N/A